NOUV Announces Goldman Small Cap Research Report Following Acquisition of Cannabis Cultivation Business
May 29 2019 - 1:29PM
InvestorsHub NewsWire
Dallas, TX -- May 29, 2019 -- InvestorsHub
NewsWire -- Nouveau, Inc. (f/k/a Nouveau Life Pharmaceuticals,
Inc.) (USOTC:
NOUV) (“NOUV”) today announced a research report published on
the company by Goldman Small Cap Research. In the fourth
quarter of last year, Puration, Inc. (USOTC: PURA) (“PURA”)
spun-off its cannabis cultivation business to NOUV.
Separately, ACI Conglomerated acquired controlling interest
in NOUV making NOUV part of a family of cannabis companies that
include PURA, and North American Cannabis Holdings, Inc. (USOTC:
USMJ). In conjunction with the spinoff of PURA’s cannabis
cultivation business to NOUV, NOUV is to issue a stock dividend to
PURA shareholders. The research report published by Goldman
Small Cap Research today is intended to provide investors with
information to support an investment decision. The report is
available on NOUV’s new website www.NOUV-INFO.com. The new website is designed
to provide investors with important details to include capital
structure, management information, financial disclosures, stock
quotation and the research report published today. NOUV has
already initiated hemp cultivation operations and plans to issue
business development updates soon.
NOUV Research Published By Goldman Small Cap
Research
About
Nouveau
The Company is an emerging cannabis
cultivator concentrating at this time on hemp cultivation within
the United States and marijuana cultivation in Canada. The
Company currently operates 25 greenhouses in the United States with
existing pads and irrigation to rapidly expand to 400
greenhouses. Revenue is generated in the United States at
this time through wholesale sales of general nursery products to
retail nurseries. The Company’s first large scale hemp
cultivation is initiating in 2019 under the 2018 Farm Act.
The Company’s strategy in the United States is to sustain and grow
greenhouse infrastructure with general nursery operations and
transition to hemp and marijuana cultivation as laws evolve and
permit. The Company’s strategy in Canada is to utilize an
existing marijuana cultivation operation as the foundation of
building a home grower product and services
business.
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Nouveau, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Apr 2023 to Apr 2024